HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Reaction

Ibudilast → 2-Isopropylpyrazolo[1,5-a]pyridine

HRID 1642337
Notes
Print preview

Reaction equation

HRID 1642337 reaction equation
[CH3:1][CH:2]([C:4]1[C:12]([C:13]([CH:15]([NH2:17])[CH3:16])=[O:14])=[C:11]2[N:6]([CH:7]=[CH:8][CH:9]=[CH:10]2)[N:5]=1)[CH3:3].[CH3:18][CH:19]([C:21]1[C:22]([C:30](C(C)C)=[O:31])=[C:23]2[N:28]([N:29]=1)[CH:27]=[CH:26][CH:25]=[CH:24]2)[CH3:20].C(C1C=C2C=CC=CN2N=1)(C)C.CC(C)C=[O:50]>>[CH3:3][CH:2]([C:4]1[C:12]([C:13]([CH:15]([NH2:17])[CH3:16])=[O:14])=[C:11]2[N:6]([CH:7]=[CH:8][CH:9]=[CH:10]2)[N:5]=1)[CH3:1].[CH:19]([C:21]1[CH:22]=[C:23]2[CH:24]=[CH:25][CH:26]=[CH:27][N:28]2[N:29]=1)([CH3:20])[CH3:18].[CH:19]([C:21]1[C:22]([C:30]([OH:31])=[O:50])=[C:23]2[CH:24]=[CH:25][CH:26]=[CH:27][N:28]2[N:29]=1)([CH3:18])[CH3:20]
ParticipantsProcedureSources & evidenceReaction notes

Participants

7

Reactant 4

HCID 3671Ibudilast2×HCID 6561IsobutyraldehydeHCID 113786582-Isopropylpyrazolo[1,5-a]pyridineHCID 236589662-Amino-1-(2-propan-2-ylpyrazolo[1,5-a]pyridin-3-yl)propan-1-one

Product 3

HCID 113786582-Isopropylpyrazolo[1,5-a]pyridine
HCID 23658966
2-Amino-1-(2-propan-2-ylpyrazolo[1,5-a]pyridin-3-yl)propan-1-one
HCID 578374592-Isopropylpyrazolo[1,5-a]pyridine-3-carboxylic acid

Procedure

According to one approach, therefore, the desired S-enantiomer of AV1013 is prepared by chiral resolution of the corresponding racemic mixture. As shown in FIG. 6, and described in the Example 1 below, synthesis of AV1013 involves several steps. The first step involves the synthesis of 2-chloro-nor-methylibudilast using either ibudilast (2-methyl-1-(2-isopropylpyrazolo[1,5-a]pyridin-3-yl)propan-1-one) or the corresponding 3-carboxylic acid (2-isopropyl-pyrazolo[1,5-a]pyridin-3-carboxylic acid, ibudilast acid) as the starting material. Thus, reacting ibudilast with an aqueous solution of a strong inorganic acid, for example, 50% aqueous sulfuric gave isopropylpyrazolo[1,5-a]pyridine (IPPP) following a loss of its 3-ring substituent (2-methyl-propan-1-one). Alternatively IPPP is obtained via the decarboxylation of 2-isopropyl-pyrazolo[1,5-a]pyridin-3-carboxylic acid under acidic conditions. See, Example 1, method 2, step 1.

Sources & evidence

ORD record
ord-7ce12f2ff7c744f4aba5a2fd737f4c0f
Source dataset
uspto-grants-2012_02
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US08119657B2

Reaction notes

Loading…

On this pageParticipantsProcedureSources & evidenceReaction notes